Pikeville Medical Center v. Genentech, Inc.

Good Law
United States District Court, Northern District of CaliforniaJune 6, 20224:22-cv-01318California407 words

Opinion

Trial Court Opinion

Wdot ING. BPO EI IN

UNITED STATES JUDICIAL PANEL F I L EK D

on

MULTIDISTRICT LITIGATION MAY 24 2022

Mark C. McCartt Cl : » Clerk

U.S. DISTRICT COURT

IN RE: GENENTECH, INC., HERCEPTIN

(TRASTUZUMAB) MARKETING AND SALES PRACTICES LITIGATION MDL No. 2700

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO —6)

On April 7, 2016, the Panel transferred 8 civil action(s) to the United States District Court for the Northern District of Oklahoma for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 178 F.Supp.3d 1374 (J.P.M.L. 2016). Since that time, 5 additional action(s) have been transferred to the Northern District of Oklahoma. With the consent of that court, all such actions have been assigned to the Honorable Terence C. Kern. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Northern District of Oklahoma and assigned to Judge Kern. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.